BackMonopar Therapeutics Overview
Monopar Therapeutics Inc

Monopar Therapeutics Discounted Cash Flow

DCF Analysis for MNPR.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$8.32

Current Fair Value

$8.32
86.5% Downside

Overvalued by 86.5% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading